Nitric oxide synthase in spontaneously hypertensive rats

Journal of Biomedical Science

Volumn 4, Issue 5, 1997, Pages 249-255

  Wu, Chin Chen ^a   Yen, Mao Hsiung ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE; QUINAPRIL;

CONFERENCE PAPER; HYPERTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

EID: 0030786733     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02253425     Document Type: Conference Paper

References (53)

1. Bates JN, Baker MT, Guerra R Jr, Harrison DG. Nitric oxide generation from nitroprusside by vascular tissue: Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol 42:S157-S165;1991.
2. Beasley D. Interleukin-1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle. Am J Physiol 259:R38-R44;1990.
3. Beasley D, Cohen RA, Levinski NG. Interleukin 1 inhibits contraction of vascular smooth muscle. J Clin Invest 83:331-335;1989.
4. Beasley D, Schwartz JH, Brenner BM. Interleukin-1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 87:602-608;1991.
5. Beulter B. TNF, immunity and inflammatory disease: Lessons of the past decade. J Invest Med 43:227-235;1995.
6. 2 purinoceptors on vascular endothelial cells: Physiological significance and transduction mechanisms. Trends Pharmacol Sci 11:34-37;1990.
7. Boulanger C, Schini VB, Moncada S, Vanhoutte PM. Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide. Br J Pharmacol 101:152-156;1990.
8. Bredt DS, Snyder SH. Nitric oxide: A physiologic messenger molecule. Annu Rev Biochem 63:175-195;1994.
9. Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle. FEBS Lett 275:87-90;1990.
10. Calver H, Collier J, Vallance P. Nitric oxide and cardiovascular control. Exp Physiol 78:303-326;1993.
11. Clozel M, Kuhn H, Hefti F, Baumgartner HR. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension: Effect of angiotensin converting enzyme inhibition. Hypertension 18:132-141;1991.
12. Culotta E, Koshland DE Jr. NO news is good news. Science 258:1862-1865;1992.
13. Dananberg J, Sider RS, Grekin RJ. Sustained hypertension induced by orally administered nitro-L-arginine. Hypertension 21:359-363;1993.
14. Diederich D, Yang Z, Buhler FR, Luscher TF. Impaired eadothelium-dependent relaxations in hypertensive resistance arteries involve cyclooxygenase pathway. Am J Physiol 258:H445-H451;1990.
15. Folkow B, Hallback M, Lundgren Y, Weiss L. Background of increased flow resistance and vascular reactivity in spontaneously hypertensive rats. Acta Physiol Scand 80:93-106;1970.
16. Forstermann U, Pollock JS, Schmidt HHHW, Heller M, Murad F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci USA 88:1788-1792;1991.
17. G-monomethyl-L-arginine in spontaneously hypertensive and normotensive Wistar-Kyotorats. Br J Pharmacol 102:823-826;1991.
18. Furchgott RF, Zawakzki TV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 228:373-376;1980.
19. Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, Ignarro LJ. Relationship between cyclic guanosine 3′,5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: Effects of methylene blue and methemoglobin. J Pharmacol Exp Ther 219:181-186;1981.
20. Hazama F, Amano S, Ozaki T. Pathological changes of cerebral vessel endothelial cells in spontaneously hypertensive rats, with special reference to the role of these cells in the development of hypertensive cerebral lesions. Adv Neurol 20:359-369;1978.
21. Humphries RG, Tomlinson W, O'Connor SE, Left P. Inhibition of collagen- and ADP-induced platelet aggregation by substance P in vivo: Involvement of endothelium-derived relaxing factor. J Cardiovasc Pharmacol 16:292-297;1990.
22. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30:535-560;1990.
23. Ignairo LJ, Buga GM, Wood KS, Byrns KS, Chaudhuri G. Endothelium-derived relaxing factor produced and release from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265-9269;1987.
24. Junquero DC, Schini VB, Scott-Burden T, Vanhoutte PM. Enhanced production of nitric oxide in aortae from spontaneously hypertensive rats by interleukin-1β. Am J Hypertens 6:602-610;1993.
25. Junquero DC, Scott-Burden T, Schini VB, Vanhoutte PM. The production of nitric oxide evoked by interleukin-1β in cultured aortic smooth muscle cells from spontaneously hypertensive rats is greater than that from normotensive rats. Gen Hypertens 218:3-5;1992.
26. Kanagy NL, Pawloski GM, Fink GD. Role of aldosterone in angiotensin II-induced hypertension in rats. Am J Physiol 259:R102-R109;1990.
27. Konishi M, Su C. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 5:881-886;1983.
28. G-nitroarginine produces an exaggerated hypertension in anesthetized SHR. Eur J Pharmacol 197:239-240;1991.
29. Lee L, Webb RC. Endothelium-dependent relaxation and L-arginine metabolism in genetic hypertension. Hypertension 19:435-441;1992.
30. Lockette W, Otsuka Y, Carretero O. The loss of endothelium dependent vascular relaxation in hypertension. Hypertension 8 (suppl II):II-61-II-66;1986.
31. Luscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 8:344-348;1986.
32. Malinski T, Kapturczak M, Dayharsh J, Bohr D. Nitric oxide synthase activity in genetic hypertension. Biochem Biophys Res Commun 194:654-658;1993.
33. Mayhan WG. Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension. Am J Physiol 259: H1455-H1462;1990.
34. Mayhan WG, Faraci FM, Heistad DD. Responses of cerebral arterioles to adenosine 5′-diphosphate, serotonin, and the thromboxane analogue U-46619 during chronic hypertension. Hypertension 12:556-561;1988.
35. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142;1991.
36. ω-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol 99:408-412;1990.
37. Mourlon-Le Grand MC, Benessiano J, Levy BI. cGMP pathway and mechanical properties of carotid artery wall in WKY rats and SHR: Role of endothelium. Am J Physiol 263:H61-H67;1992.
38. G-L-Nitro-arginine [N5 - imino (nitroamino) methyl - L - ornithine] impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from larginine. Naunyn-Schmiedeberg's Arch Pharmacol 341:143-147;1990.
39. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064;1992.
40. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. Nature 327:524-526;1987.
41. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323:22-27;1990.
42. Papapetropoulos A, Marczin N, Snead MD, Cheng C, Milici A, Catravas JD. Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats. Hypertension 23:476-484;1994.
43. Parker JL, Adams HR. Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ Res 72:539-551;1993.
44. 2 purinoceptors in the cardiovascular system. Circulation 84:1-14;1991.
45. Schi VB, Junquero DC, Scott-Burden T, Vanhoutte PM. Interleukin-1β induces the production of an L-arginine-derived relaxing factor from cultured smooth cells from rat aorta. Biochem Biophys Res Commun 176:114-121;1991.
46. Schini-Kerth VB, Vanhoutte PM. Nitric oxide synthases in vascular cells. Exp Physiol 80:885-905;1995.
47. G-nitro-L-arginine methyl ester. J Hypertens 9 (suppl 6):S192-S193;1991.
48. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redoxactivated forms. Science 251:1898-1901;1992.
49. Wu CC, Hong HJ, Chou TC, Ding YA, Yen MH. Evidence for inducible nitric oxide synthase in spontaneously hypertensive rats. Biochem Biophys Res Commun 228:459-466;1996.
50. Xiao J, Pang PKT. Does a general alteration in nitric oxide synthesis system occur in spontaneously hypertensive rats? Am J Physiol 266: H272-H278;1994.
51. Xiao J, Pang PKT. Activation of nitric oxide synthesis in vascular smooth muscle cells and macrophages during development in spontaneously hypertensive rats. Am J Hypertens 9:377-384;1996.
52. Yen MH, Liu YC, Hong HJ, Sheu JR, Wu CC. Role of nitric oxide in lipopolysaccharide-induced mortality from spontaneously hypertensive rats. Life Sci 60:1223-1230;1997.
53. Young RH, Ding YA, Lee YM, Yen MH. Cilazapril reverses endothelium-dependent vasodilator response to acetylcholine in mesenteric artery from spontaneously hypertensive rats. Am J Hypertens 8:928-933;1995.